Mikko Tenhunen

Helsinki University Hospital, University of Helsinki

Papers

2

Total Citations

43

H-Index

2

About

Mikko Tenhunen is a leading Finnish medical physicist whose work has advanced the precision and safety of radiation oncology, with a particular focus on stereotactic body radiotherapy (SBRT) and boron neutron capture therapy (BNCT). His research bridges the critical gap between dosimetric theory and clinical application, ensuring that cutting-edge radiation techniques are both effective and deliverable. In a landmark 2016 study (25 citations), Tenhunen systematically compared four SBRT techniques for prostate cancer, providing the first comprehensive dosimetric evaluation of their monitor units and delivery efficiency—a study that has directly informed clinical protocols for high-precision treatment. More recently, his 2022 review (18 citations) of Finland’s transition from nuclear reactor-based to proton accelerator-based BNCT documented the outcomes of 249 patients treated at Helsinki University Hospital, establishing a vital roadmap for the global adoption of accelerator-based neutron sources. Tenhunen’s work is distinguished by its rigorous methodology and direct impact on patient care, making him a key figure in the evolution of both SBRT and BNCT. His contributions have not only shaped Finnish radiotherapy practice but have also provided an evidence-based foundation for centers worldwide transitioning to more advanced treatment modalities.

Research Focus

Key Achievements

2
H-Index
2
Papers
43
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer
25 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Helsinki University Hospital, University of Helsinki

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago